Inventor
NICULESCU-DUVAZ DAN
GB25 patents
⚠️ This page may combine multiple inventors who share the name “NICULESCU-DUVAZ DAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CANCER REC TECH LTD
6 patentsUS6916949B2Jul 12, 2005
Methods of chemical systhesis of phenolic nitrogen mustard prodrugs
CANCER REC TECH LTD62 citations96
US7951819B2May 31, 2011
Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compounds
CANCER REC TECH LTD37 citations90
US9120789B2Sep 1, 2015
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
CANCER REC TECH LTD7 citations83
US8912191B2Dec 16, 2014
Pyrido[2,3-B]pyrazin-8-substituted compounds and their use
CANCER REC TECH LTD8 citations83
US8383816B2Feb 26, 2013
Aryl-quinolyl compounds and their use
CANCER REC TECH LTD13 citations81
US7625922B2Dec 1, 2009
Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
CANCER REC TECH LTD19 citations78
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL
6 patentsUS10995088B2May 4, 2021
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2 citations69
US10807974B2Oct 20, 2020
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL2 citations69
US11608330B2Mar 21, 2023
Methylamine derivatives as lysysl oxidase inhibitors for the treatment of cancer
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations59
US12060360B2Aug 13, 2024
Lysyl oxidase inhibitors
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations58
US11325915B2May 10, 2022
Lysyl oxidase inhibitors
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL1 citations58
US12018029B2Jun 25, 2024
Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors
THE INSTITUTE OF CANCER RES ROYAL CANCER HOSPITAL0 citations45
CANCER RES TECH LTD
3 patentsUS9439893B2Sep 13, 2016
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
CANCER RES TECH LTD4 citations83
US9725447B2Aug 8, 2017
1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer
CANCER RES TECH LTD8 citations82
US9708317B2Jul 18, 2017
Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivatives
CANCER RES TECH LTD2 citations72
CANCER RESEARCH TECH LTD
3 patentsUS9820976B2Nov 21, 2017
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
CANCER RESEARCH TECH LTD1 citations62
US10100053B2Oct 16, 2018
Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivatives
CANCER RESEARCH TECH LTD0 citations51
US10167282B2Jan 1, 2019
1-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido [2, 3-B]pyrazin- 8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancer
CANCER RESEARCH TECH LTD0 citations50
SPRINGER CAROLINE JOY
2 patentsCANCER RES INST ROYAL
2 patentsINST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)
2 patentsUS9540372B2Jan 10, 2017
Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)1 citations57
US9611223B2Apr 4, 2017
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use
INST OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE)0 citations29